Evidence map›Paper›PMID 24699552›Full record

ArticlePloS one2014

Spink2 modulates apoptotic susceptibility and is a candidate gene in the Rgcs1 QTL that affects retinal ganglion cell death after optic nerve damage.

Joel A Dietz, Margaret E Maes, Shuang Huang, Brian S Yandell, Cassandra L Schlamp, Angela D Montgomery, R Rand Allingham, Michael A Hauser, Robert W Nickells

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Upregulation of SPINK2 in acute myeloid leukemia.Advances in laboratory medicine · 2023
    Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Joel A DietzDepartment of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin, United States of America.
Margaret E MaesDepartment of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin, United States of America.
Shuang HuangDepartment of Biostatistics, University of Wisconsin, Madison, Wisconsin, United States of America.
Brian S YandellDepartment of Biostatistics, University of Wisconsin, Madison, Wisconsin, United States of America.
Cassandra L SchlampDepartment of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin, United States of America.
Angela D MontgomeryDepartment of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin, United States of America.
R Rand AllinghamCenter for Human Genetics, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Michael A HauserCenter for Human Genetics, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Robert W NickellsDepartment of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin, United States of America.
University of Wisconsin–Madison · USDuke Medical Center · USDuke University Hospital · US

Funding

UW Vision Research Core - Administrative CoreP30EY016665 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI ROBERT W NICKELLS · 2005 to 2026
$12.6M
Characterization of RGC death susceptibility allelesR01EY018869 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI NICKELLS, ROBERT W · 2009 to 2013
$1.5M
NEI NIH HHS P30 EY016665NEI NIH HHS R01 EY018869NEI NIH HHS R01EY018869
6 · The paper itself

Abstract

The Rgcs1 quantitative trait locus, on mouse chromosome 5, influences susceptibility of retinal ganglion cells to acute damage of the optic nerve. Normally resistant mice (DBA/2J) congenic for the susceptible allele from BALB/cByJ mice exhibit susceptibility to ganglion cells, not only in acute optic nerve crush, but also to chronic inherited glaucoma that is characteristic of the DBA/2J strain as they age. SNP mapping of this QTL has narrowed the region of interest to 1 Mb. In this region, a single gene (Spink2) is the most likely candidate for this effect. Spink2 is expressed in retinal ganglion cells and is increased after optic nerve damage. This gene is also polymorphic between resistant and susceptible strains, containing a single conserved amino acid change (threonine to serine) and a 220 bp deletion in intron 1 that may quantitatively alter endogenous expression levels between strains. Overexpression of the different variants of Spink2 in D407 tissue culture cells also increases their susceptibility to the apoptosis-inducing agent staurosporine in a manner consistent with the differential susceptibility between the DBA/2J and BALB/cByJ strains.

Indexed as

Quantitative Trait LociAnimalsApoptosisBase SequenceDNAMiceMice, Inbred BALB CMice, Inbred DBAMolecular Sequence DataOptic NervePolymorphism, Single NucleotideRetinal Ganglion CellsSerine Peptidase Inhibitors, Kazal TypeSerpinsDNASerine Peptidase Inhibitors, Kazal TypeSerpinsSPINK2 protein, mouse

Identifiers

PMID24699552
PMCPMC3974755
OpenAlexW2021209097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.